140 related articles for article (PubMed ID: 30113647)
1. Cardiometabolic Biomarkers and Their Temporal Patterns Predict Poor Outcome in Chronic Heart Failure (Bio-SHiFT Study).
Brankovic M; Akkerhuis KM; Mouthaan H; Brugts JJ; Manintveld OC; van Ramshorst J; Germans T; Umans V; Boersma E; Kardys I
J Clin Endocrinol Metab; 2018 Nov; 103(11):3954-3964. PubMed ID: 30113647
[TBL] [Abstract][Full Text] [Related]
2. Utility of temporal profiles of new cardio-renal and pulmonary candidate biomarkers in chronic heart failure.
Brankovic M; Martijn Akkerhuis K; Mouthaan H; Constantinescu A; Caliskan K; van Ramshorst J; Germans T; Umans V; Kardys I
Int J Cardiol; 2019 Feb; 276():157-165. PubMed ID: 30098826
[TBL] [Abstract][Full Text] [Related]
3. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study.
Brankovic M; Akkerhuis KM; van Boven N; Anroedh S; Constantinescu A; Caliskan K; Manintveld O; Cornel JH; Baart S; Rizopoulos D; Hillege H; Boersma E; Umans V; Kardys I
Kidney Int; 2018 Apr; 93(4):952-960. PubMed ID: 29191357
[TBL] [Abstract][Full Text] [Related]
4. Temporal Patterns of 14 Blood Biomarker candidates of Cardiac Remodeling in Relation to Prognosis of Patients With Chronic Heart Failure-The Bio- SH i FT Study.
Bouwens E; Brankovic M; Mouthaan H; Baart S; Rizopoulos D; van Boven N; Caliskan K; Manintveld O; Germans T; van Ramshorst J; Umans V; Akkerhuis KM; Kardys I
J Am Heart Assoc; 2019 Feb; 8(4):e009555. PubMed ID: 30760105
[TBL] [Abstract][Full Text] [Related]
5. Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study.
van Boven N; Akkerhuis KM; Anroedh SS; Rizopoulos D; Pinto Y; Battes LC; Hillege HL; Caliskan KC; Germans T; Manintveld OC; Cornel JH; Constantinescu AA; Boersma E; Umans VA; Kardys I
Int J Cardiol; 2017 May; 235():124-132. PubMed ID: 28274577
[TBL] [Abstract][Full Text] [Related]
6. Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study.
van den Berg VJ; Bouwens E; Umans VAWM; de Maat M; Manintveld OC; Caliskan K; Constantinescu AA; Mouthaan H; Cornel JH; Baart S; Akkerhuis KM; Boersma E; Kardys I
Thromb Haemost; 2019 Dec; 119(12):1947-1955. PubMed ID: 31659734
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-binding protein 7 and risk of congestive heart failure hospitalization in patients with atrial fibrillation.
Blum S; Aeschbacher S; Meyre P; Kühne M; Rodondi N; Beer JH; Ammann P; Moschovitis G; Bonati LH; Blum MR; Kastner P; Baguley F; Sticherling C; Osswald S; Conen D;
Heart Rhythm; 2021 Apr; 18(4):512-519. PubMed ID: 33278630
[TBL] [Abstract][Full Text] [Related]
8. Temporal evolution of liver function parameters predicts clinical outcome in chronic heart failure patients (Bio-SHiFT study).
Klimczak-Tomaniak D; Andrzejczyk K; Abou Kamar S; Baart S; van Boven N; Akkerhuis KM; Constantinescu A; Caliskan K; Simsek S; Germanse T; van Ramshorst J; Brugts J; Kuch M; Umans V; Boersma E; Kardys I
Cardiol J; 2024; 31(3):409-417. PubMed ID: 38408202
[TBL] [Abstract][Full Text] [Related]
9. Coronary Sinus Neuropeptide Y Levels and Adverse Outcomes in Patients With Stable Chronic Heart Failure.
Ajijola OA; Chatterjee NA; Gonzales MJ; Gornbein J; Liu K; Li D; Paterson DJ; Shivkumar K; Singh JP; Herring N
JAMA Cardiol; 2020 Mar; 5(3):318-325. PubMed ID: 31876927
[TBL] [Abstract][Full Text] [Related]
10. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
[TBL] [Abstract][Full Text] [Related]
11. HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.
Piek A; Meijers WC; Schroten NF; Gansevoort RT; de Boer RA; Silljé HH
J Card Fail; 2017 Jan; 23(1):12-19. PubMed ID: 27224553
[TBL] [Abstract][Full Text] [Related]
12. Serially Measured Cytokines and Cytokine Receptors in Relation to Clinical Outcome in Patients With Stable Heart Failure.
Bouwens E; Schuurman AS; Akkerhuis KM; Baart SJ; Caliskan K; Brugts JJ; van Ramshorst J; Germans T; Umans VAWM; Boersma E; Kardys I
Can J Cardiol; 2020 Oct; 36(10):1587-1591. PubMed ID: 32827637
[TBL] [Abstract][Full Text] [Related]
13. [Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death].
Mazovets OL; Trifonov IR; Katrukha AG; Bereznikova AV; Medvedeva MV; Deev AD; Gratsianksiĭ NA
Kardiologiia; 2008; 48(1):24-9. PubMed ID: 18260992
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.
Aimo A; Januzzi JL; Vergaro G; Ripoli A; Latini R; Masson S; Magnoli M; Anand IS; Cohn JN; Tavazzi L; Tognoni G; Gravning J; Ueland T; Nymo SH; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; de Boer RA; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Tentzeris I; Tang WHW; Grodin J; Passino C; Emdin M
Circulation; 2018 Jan; 137(3):286-297. PubMed ID: 29335288
[TBL] [Abstract][Full Text] [Related]
15. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of myocardial damage markers in patients with chronic heart failure with atrial fibrillation.
Otaki Y; Arimoto T; Takahashi H; Kadowaki S; Ishigaki D; Narumi T; Honda Y; Iwayama T; Nishiyama S; Shishido T; Miyashita T; Miyamoto T; Watanabe T; Kubota I
Intern Med; 2014; 53(7):661-8. PubMed ID: 24694473
[TBL] [Abstract][Full Text] [Related]
18. Cardiac troponin T vs other biochemical markers in patients with congestive heart failure.
Nishio Y; Sato Y; Taniguchi R; Shizuta S; Doi T; Morimoto T; Kimura T; Kita T
Circ J; 2007 May; 71(5):631-5. PubMed ID: 17456983
[TBL] [Abstract][Full Text] [Related]
19. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
20. Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.
Tziakas DN; Chalikias GK; Stakos D; Chatzikyriakou SV; Papazoglou D; Mitrousi K; Lantzouraki A; Thomaidi A; Boudoulas H; Konstantinides S
Eur J Prev Cardiol; 2012 Feb; 19(1):62-71. PubMed ID: 20479644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
